New Amsterdam Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.29M | Sell |
11,007
-944
| -8% | -$111K | 0.47% | 66 |
|
|
2018
Q4 | $1.3M | Sell |
11,951
-1,413
| -11% | -$154K | 0.43% | 74 |
|
|
2018
Q3 | $1.71M | Sell |
13,364
-284
| -2% | -$36.3K | 0.44% | 78 |
|
|
2018
Q2 | $1.54M | Sell |
13,648
-661
| -5% | -$74.8K | 0.37% | 82 |
|
|
2018
Q1 | $1.61M | Sell |
14,309
-19,543
| -58% | -$2.2M | 0.35% | 80 |
|
|
2017
Q4 | $5.01M | Sell |
33,852
-882
| -3% | -$130K | 1% | 45 |
|
|
2017
Q3 | $4.07M | Sell |
34,734
-3,277
| -9% | -$384K | 0.85% | 48 |
|
|
2017
Q2 | $4.93M | Sell |
38,011
-760
| -2% | -$98.6K | 1.05% | 43 |
|
|
2017
Q1 | $5.25M | Sell |
38,771
-2,355
| -6% | -$319K | 1.24% | 26 |
|
|
2016
Q4 | $5.9M | Sell |
41,126
-5,282
| -11% | -$758K | 1.34% | 26 |
|
|
2016
Q3 | $5.48M | Buy |
46,408
+4,139
| +10% | +$489K | 1.26% | 30 |
|
|
2016
Q2 | $4.48M | Buy |
42,269
+8,496
| +25% | +$900K | 1.09% | 39 |
|
|
2016
Q1 | $3.76M | Buy |
33,773
+4,758
| +16% | +$530K | 0.39% | 70 |
|
|
2015
Q4 | $4.54M | Sell |
29,015
-78,451
| -73% | -$12.3M | 0.47% | 63 |
|
|
2015
Q3 | $14.1M | Sell |
107,466
-10,606
| -9% | -$1.39M | 1.43% | 33 |
|
|
2015
Q2 | $20.5M | Buy |
118,072
+3,696
| +3% | +$643K | 1.77% | 27 |
|
|
2015
Q1 | $19.7M | Sell |
114,376
-43,815
| -28% | -$7.56M | 1.59% | 29 |
|
|
2014
Q4 | $20.5M | Sell |
158,191
-176,076
| -53% | -$22.8M | 1.78% | 20 |
|
|
2014
Q3 | $43M | Buy |
334,267
+57,756
| +21% | +$7.43M | 2.88% | 1 |
|
|
2014
Q2 | $24.5M | Sell |
276,511
-32,445
| -11% | -$2.87M | 1.59% | 26 |
|
|
2014
Q1 | $29.1M | Buy |
+308,956
| New | +$29.1M | 1.99% | 20 |
|
|
2013
Q4 | – | Sell |
-409,762
| Closed | -$32.3M | – | 138 |
|
|
2013
Q3 | $32.3M | Buy |
409,762
+3,437
| +0.8% | +$271K | 2.16% | 14 |
|
|
2013
Q2 | $26.7M | Buy |
+406,325
| New | +$26.7M | 1.43% | 22 |
|